These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7995362

  • 1. Low prevalence of antibody to human parvovirus B19 in Singapore.
    Matsunaga Y, Goh KT, Utagawa E, Muroi N.
    Epidemiol Infect; 1994 Dec; 113(3):537-40. PubMed ID: 7995362
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Parvovirus B19 infection in Hong Kong.
    Lim WL, Wong KF, Lau CS.
    J Infect; 1997 Nov; 35(3):247-9. PubMed ID: 9459396
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A school outbreak of parvovirus B19 infection investigated using salivary antibody assays.
    Rice PS, Cohen BJ.
    Epidemiol Infect; 1996 Jun; 116(3):331-8. PubMed ID: 8666078
    [Abstract] [Full Text] [Related]

  • 9. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies.
    Nigro G, Luzi G, Fridell E, Ferrara M, Pisano P, Gattinara GC, Mezzaroma I, Söderlund M, Rasnoveanu D, Aiuti F.
    AIDS; 1992 Jul; 6(7):679-84. PubMed ID: 1503687
    [Abstract] [Full Text] [Related]

  • 10. [Seroepidemiology of human parvovirus B19 using recombinant VP1 + VP2 particle antigen].
    Matsunaga Y, Takeda N, Yamazaki S, Kamata K, Kurosawa D.
    Kansenshogaku Zasshi; 1995 Dec; 69(12):1371-5. PubMed ID: 8586889
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Parvovirus B19 infection: the general aspects and gestational problems].
    Di Stefano L, Carta G, Barnabei R, Tomei E, Toro G, Moscarini M.
    Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
    [Abstract] [Full Text] [Related]

  • 13. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
    Grosse-Bley A, Eis-Hübinger AM, Kaiser R, Oldenburg J, Brackmann HH, Schwarz TF, Schneweis KE.
    Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Parvovirus B19 antibodies in patients with haemophilia A.
    Peerlinck K, Goubau P, Reybrouck R, Desmyter J, Vermylen J.
    Thromb Haemost; 1995 Mar; 73(3):555-6. PubMed ID: 7667846
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity.
    Gray JJ, Cohen BJ, Desselberger U.
    J Virol Methods; 1993 Sep; 44(1):11-23. PubMed ID: 8227275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.